Table 3.
Metabolite annotation and pathway enrichment analysis using Mummichog for negative ion m/z features present in the native and allograft BAL fluid. * P < 0.05, Native vs Allograft samples with less enrichment of these pathways. Fischer’s Exact test was used for comparison and generation of enrichment P values. P-values for all pathways were then modeled as a Gamma distribution and then adjusted for the permutations
| Pathways | Pathway Size | Adjusted P Value |
|---|---|---|
| Purine Metabolism | 22 | 0.001 |
| Methionine and Cysteine Metabolism | 13 | 0.002 |
| Denovo-Fatty acid biosynthesis | 10 | 0.002 |
| Fatty acid activation | 7 | 0.003 |
| Vitamin B5-CoA biosynthesis | 7 | 0.003 |
| Aspartate and Aspargine Metabolism | 21 | 0.003 |
| Alanine and Aspartate Metabolism | 5 | 0.005 |
| Arginine and Proline Metabolism | 9 | 0.006 |
| Drug Metabolism CYP 450 | 33 | 0.008 |
| Saturated fatty acid beta-oxidation | 2 | 0.008 |
| Phosphatidylinositol Phosphate Metabolism | 6 | 0.009 |
| TCA Cycle | 3 | 0.01 |
| Alkaloid Biosynthesis II | 3 | 0.01 |
| Urea cycle | 20 | 0.01 |
| Pyrimidine Metabolism | 13 | 0.03 |
| Dynorphin Metabolism | 4 | 0.03 |
| Omega 3 Fatty acid Metabolism | 4 | 0.03 |
| COA Metabolism | 4 | 0.03 |
| Fatty acid Metabolism | 4 | 0.03 |
| Vitamin E Metabolism | 27 | 0.03 |
| Linoleate Metabolism | 9 | 0.03 |